- 2022 year
- 2021 year
- 2020 year
- 2019 year
- 2018 year
- 2017 year
- 2016 year
- 2015 year
- 2014 year
- 2013 year
- 2012 year
"InterChem" developed and brought to market a new form of the drug "Gidazepam ІC®" - sublingual tablets
Sublingual form of benzodiazepines are used to control anxiety and prevention of emotional stress, such as for patients before surgery and dental procedures. Such well-known drugs like lorazepam, zolpidem, clonazepam are available in sublingual form.
Sublingual form of the drug "Gidazepam IC®" allows to accelerate onset of action of the drug, which is especially valuable in urgent situations - before surgery and diagnostic procedures (eg, endoscopic examination), and also allows to use the drug in an environment where oral administration is impossible or difficult - lack of drinking water, difficulty swallowing.
"Gidazepam IC®" belongs to the group of benzodiazepines. It has action of "daytime" tranquilizer and selective anxiolytic. "Gidazepam IC®" has an original range of pharmacological activity, combining the anxiolytic and activating action with the antidepressant components. The maximum effect is reached within 1-4 hours, followed by gradual weakening.
Indications for use:
- neurotic, psychopathic asthenia;
- conditions accompanied by anxiety, fear (including fear of painful surgery and diagnostic examinations), increased irritability, sleep disorders;
- emotional lability;
- relief of withdrawal symptoms of alcoholism;
- supportive therapy during remission in chronic alcoholism;
- logoneurosis, migraine.